Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-216901
Filing Date
2026-05-11
Accepted
2026-05-11 16:30:04
Documents
2
Period of Report
2026-05-11

Document Format Files

Seq Description Document Type Size
1 6-K clls_6-k_q1_2026.htm 6-K 30105
2 EX-99.1 clls-ex99_1.htm EX-99.1 2982794
  Complete submission text file 0001193125-26-216901.txt   3014020
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE France
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE France 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36891 | Film No.: 26963651
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)